广州，7月15日电 (记者 蔡敏婕) 由(中国)阿尔茨海默病防治协会与广药集团共同主办的“2024年国际阿尔茨海默病及相关病国际学术大会”于13日至15日在广州成功举行。本次大会以“深化国际合作，共筑健康未来”为主题，吸引了全球范围内的专家学者、研究者以及相关领域的专业人士参与，共同探讨阿尔茨海默病的最新研究进展、治疗策略、预防方法以及国际合作的机遇与挑战。
大会期间，与会嘉宾们围绕阿尔茨海默病的临床表现、病理机制、早期诊断、干预治疗、康复护理等议题展开了深入的交流与讨论。同时，大会还特别设置了专题报告、圆桌讨论、病例分享等环节，旨在促进国际间学术交流与合作，共同推动阿尔茨海默病及相关疾病的预防、诊断和治疗水平的提升。
广药集团作为本次大会的共同主办方，展示了其在阿尔茨海默病领域的一系列研究成果和创新药物，强调了通过科研合作、成果转化等方式，促进健康事业的发展，为全球阿尔茨海默病患者提供更优质的医疗服务和治疗方案。
(中国)阿尔茨海默病防治协会在大会中强调了国际合作的重要性，呼吁全球科研机构、医疗机构和非政府组织加强合作，共享资源，共同应对阿尔茨海默病这一全球性健康挑战。协会还表示，将继续推动阿尔茨海默病的科学研究，提升公众对疾病的认识，促进疾病的早期诊断和有效治疗，以期为全球患者带来福祉。
本次国际学术大会的成功举办，不仅为全球阿尔茨海默病及相关病研究者提供了一个交流与合作的平台，也进一步推动了我国在这一领域与国际的接轨，对于提升我国在阿尔茨海默病研究和治疗领域的国际影响力具有重要意义。
英语如下：
News Title: “International Alzheimer’s Disease Academic Conference Held in穗, Discussing New Advances in Disease Prevention and Treatment”
Keywords: International Academic Conference, Alzheimer’s Disease, Held in穗
News Content: Title: The 2024 International Alzheimer’s Disease and Related Disorders Academic Conference Held in穗
穗, July 15 (Xinhua/Cai Minjie) – The “2024 International Alzheimer’s Disease and Related Disorders Academic Conference”, jointly hosted by the Alzheimer’s Disease Prevention Association of China and Guangzhou Pharmaceutical Group, was successfully held in穗from July 13 to 15. The conference, themed “Deepening International Cooperation, Building a Healthy Future Together”, attracted scholars, researchers, and professionals from various fields around the world to discuss the latest research progress, treatment strategies, preventive methods, and opportunities and challenges of international cooperation in Alzheimer’s disease.
During the conference, participants engaged in in-depth discussions on topics such as the clinical manifestations, pathogenic mechanisms, early diagnosis, intervention treatment, and rehabilitation care of Alzheimer’s disease. Special sessions including keynote speeches, roundtable discussions, and case sharing were also organized to promote academic exchanges and cooperation among countries, aiming to enhance the prevention, diagnosis, and treatment levels of Alzheimer’s disease and related disorders.
Guangzhou Pharmaceutical Group, as one of the co-hosts of the conference, showcased a series of research results and innovative drugs in the field of Alzheimer’s disease, emphasizing the importance of promoting the development of the health industry through scientific research cooperation and technology transfer.
The Alzheimer’s Disease Prevention Association highlighted the importance of international cooperation, calling on global research institutions, medical institutions, and non-governmental organizations to strengthen cooperation, share resources, and jointly address the global health challenge of Alzheimer’s disease. The association also pledged to continue to promote Alzheimer’s disease research, increase public awareness of the disease, facilitate early diagnosis and effective treatment, with the aim of bringing benefits to global patients.
The successful holding of this international academic conference not only provided a platform for global researchers in Alzheimer’s disease and related disorders to exchange and cooperate, but also further promoted China’s alignment with the international community in this field. It is of significant importance for enhancing China’s international influence in Alzheimer’s disease research and treatment.
【来源】http://www.chinanews.com/life/2024/07-15/10251609.shtml
Views: 2